Summit Therapeutics updates ivonescimab survival data ahead of FDA decision date

biopharmadive.com·Jul 22, 2026 · 1 mese fa

Summit counters PD-1/VEGF skeptics; Celldex drug fails skin disease study

endpoints.news·Jul 22, 2026 · 1 mese fa

Summit reports two-year survival data for Western patients, though context lacking

benzinga.com·Jul 22, 2026 · 1 mese fa

Summit Therapeutics Says Extended Follow-Up Reveals Stronger Survival Advantages with lead Cancer Drug -